Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Abeona Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was -160.3%. For fiscal 2025 it was 1223.1%, against -1548.2% the year before. The highest annual figure on record is 1223.1% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1223.1% | +2771.3 |
| FY2023 | Dec 31, 2023 | -1548.2% | +1259.1 |
| FY2022 | Dec 31, 2022 | -2807.4% | +23.8 |
| FY2021 | Dec 31, 2021 | -2831.2% | −1988.9 |
| FY2020 | Dec 31, 2020 | -842.3% | +1048.0 |
| FY2018 | Dec 31, 2018 | -1890.3% | +1373.6 |
| FY2017 | Dec 31, 2017 | -3263.9% | −803.5 |
| FY2016 | Dec 31, 2016 | -2460.4% | −1063.7 |
| FY2015 | Dec 31, 2015 | -1396.7% | +1498.2 |
| FY2014 | Dec 31, 2014 | -2894.9% | −3112.8 |
| FY2013 | Dec 31, 2013 | 217.9% | +457.0 |
| FY2012 | Dec 31, 2012 | -239.1% | −101.5 |
| FY2011 | Dec 31, 2011 | -137.7% | +1429.3 |
| FY2010 | Dec 31, 2010 | -1566.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -35.6% | −27243.9 |
| Q2 FY2026 | Jun 30, 2026 | -177.4% | +298.4 |
| Q1 FY2026 | Mar 31, 2026 | -195.8% | +10276.2 |
| Q4 FY2025 | Dec 31, 2025 | -377.5% | +32.2 |
| Q2 FY2025 | Jun 30, 2025 | 27208.3% | +33579.3 |
| Q2 FY2023 | Jun 30, 2023 | -475.8% | +51.8 |
| Q4 FY2022 | Dec 31, 2022 | -10472.1% | −10368.7 |
| Q2 FY2022 | Jun 30, 2022 | -409.7% | +3216.6 |
| Q1 FY2022 | Mar 31, 2022 | -6371.1% | −5410.4 |
| Q4 FY2020 | Dec 31, 2020 | -527.6% | +3908.3 |
| Q3 FY2020 | Sep 30, 2020 | -103.4% | +1879.7 |
| Q4 FY2018 | Dec 31, 2018 | -3626.3% | +303.9 |
| Q3 FY2018 | Sep 30, 2018 | -960.7% | +1479.0 |
| Q2 FY2018 | Jun 30, 2018 | -4435.9% | −620.7 |
| Q1 FY2018 | Mar 31, 2018 | -1983.1% | +837.9 |
| Q4 FY2017 | Dec 31, 2017 | -3930.2% | −1195.1 |
| Q3 FY2017 | Sep 30, 2017 | -2439.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -3815.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -2821.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -2735.2% | – |
See a number that looks wrong?